Ngarep > Produk > API > Siklofosfamid
Siklofosfamid
  • SiklofosfamidSiklofosfamid

Siklofosfamid

Jeneng produk: Cyclophosphamide
Formula Molekul: C7H15Cl2N2O2P
Bobot Molekul: 261.09
Nomer Registri CAS: 50-18-0

Model:CAS NO:50-18-0

Kirim Pitakonan

Deskripsi Produk

Siklofosfamid

jeneng produk:Siklofosfamid 50-18-0
Nomer CAS:50-18-0
Spesifikasi: In-house 
jeneng Siklofosfamid
sinonim (Bis(chloro-2-etil)amino)-2-tetrahydro-3,4,5,6-oxazaphosphorine-1,3,2-oxide-2hydrate;2-(Bis(2-chloroethyl)amino)-2H- 1,3, 2-oxazaphosphorine2-oxide; 2H-1,3,2-Oxazaphosphorin-2-amine, N, N-bis(2-chloroethyl)tetrahydro-,2-oxide;2-H-1,3,2-OxazChemic albookaphosphorinane;2H-1,3,2-Oxazaphosphosphorin-2-amine,N,N-bis(2-chloroethyl)tetrahydro-,2-oxide;1-(Bis(2-chloroethyl) amino)-1-oxo-2-aza-5-oxaphosphoridine;2-(Di(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphacyclohexane2-oxide; Siklofosfamid
copyRight
Struktur Molekul CAS # 654671-78-0 (790712-60-6), Sitagliptin phosphate, 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate
Formula Molekul C7H15Cl2N2O2P
Bobot Molekul 261.09
Nomer Registry CAS 50-18-0


Penanganan lan panyimpenan
Pancegahan kanggo nangani aman
Ora mbukak geni. Nangani ing panggonan sing ventilasi apik. Nganggo sandhangan protèktif sing cocog. Aja kontak karo kulit lan mata. Nyegah pembentukan bledug lan aerosol. Gunakake alat non-sparking. Nyegah geni sing disebabake dening uap discharge elektrostatik.
Kahanan kanggo panyimpenan sing aman, kalebu incompatibilities
Dipisahake saka panganan lan panganan. Waca Bebaya Kimia. garing. Tetep ing peteng. Tutup kanthi apik. Cyclophosphamide kudu disimpen ing wadhah sing ketat, ing suhu antara 2 & 32 derajat C.

Panggunaan pungkasan khusus: Bahan kimia laboratorium, mung kanggo riset lan pangembangan ilmiah




Hot Tags: Cyclophosphamide, China, Pemasok, Produsen, Pabrik
Kategori sing gegandhengan
Kirim Pitakonan
Mangga bebas menehi pitakon ing formulir ing ngisor iki. Kita bakal mangsuli sampeyan ing 24 jam.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept